TCL Archive ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma. December 10, 2004
TCL Archive Platinum-Free Break Enhances Therapy After First Relapse In Ovarian Cancer March 28, 2003
TCL Archive Rall Says NTP Must Have New Positions To Spend Extra $23 Million On Testing More Chemicals September 7, 1979